The "Global Regorafenib Market" size was valued at US$ 784.5 Million in 2024 and is projected to reach US$ 1120.0 million by 2030, at a CAGR of 6.1% during the forecast period 2024-2030.
"United States Regorafenib Market" size was valued at US$ 342.8 Million in 2024 and is projected to reach US$ 478.6 Million by 2030, at a CAGR of 5.7% during the forecast period 2024-2030.
Regorafenib is an oral multi-kinase inhibitor that targets various enzymes involved in cancer growth and progression. It is primarily used in the treatment of certain cancers, such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). Below are key points about Regorafenib:
-
Mechanism of Action:
- Regorafenib works by inhibiting multiple protein kinases involved in tumor angiogenesis, oncogenesis, and the tumor microenvironment, such as VEGFR, KIT, PDGFR, and FGFR.
-
FDA Approval:
- Approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced colorectal cancer, GIST after disease progression, and hepatocellular carcinoma after other treatments.
-
Indications:
- Used for patients with metastatic colorectal cancer, advanced gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma.
-
Administration:
- It is an oral medication taken once daily for 21 days followed by a 7-day rest period in a 28-day cycle.
-
Side Effects:
- Common side effects include fatigue, hand-foot skin reactions, diarrhea, high blood pressure, and liver toxicity.
-
Targeted Therapy:
- It is classified as a targeted therapy due to its ability to specifically inhibit cancer-related kinases without affecting normal cells as much as traditional chemotherapy.
-
Resistance:
- Some patients may develop resistance to regorafenib, often requiring combination therapies or switching to other treatment regimens.
-
Clinical Trials:
- Ongoing research aims to explore additional uses of regorafenib in other types of cancers and in combination with other therapies.
Report Overview:
This report provides a deep insight into the global Regorafenib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Regorafenib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Regorafenib market in any manner.
Global Regorafenib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bayer Pharmaceuticals
- Beacon Pharmaceuticals
- Drug International
By Type
- Bottled Packaging
- Film Coated Packaging
By Application
- Metastatic Colorectal Cancer
- Advanced Gastrointestinal Stromal Tumours
- Advanced Hepatocellular Carcinoma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Regorafenib Market
- Overview of the regional outlook of the Regorafenib Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Regorafenib
1.2 Key Market Segments
1.2.1 Regorafenib Segment by Type
1.2.2 Regorafenib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Regorafenib Market Overview
2.1 Global Market Overview
2.1.1 Global Regorafenib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Regorafenib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Regorafenib Market Competitive Landscape
3.1 Global Regorafenib Sales by Manufacturers (2019-2024)
3.2 Global Regorafenib Revenue Market Share by Manufacturers (2019-2024)
3.3 Regorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Regorafenib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Regorafenib Sales Sites, Area Served, Product Type
3.6 Regorafenib Market Competitive Situation and Trends
3.6.1 Regorafenib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Regorafenib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Regorafenib Industry Chain Analysis
4.1 Regorafenib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Regorafenib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Regorafenib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Regorafenib Sales Market Share by Type (2019-2024)
6.3 Global Regorafenib Market Size Market Share by Type (2019-2024)
6.4 Global Regorafenib Price by Type (2019-2024)
7 Regorafenib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Regorafenib Market Sales by Application (2019-2024)
7.3 Global Regorafenib Market Size (M USD) by Application (2019-2024)
7.4 Global Regorafenib Sales Growth Rate by Application (2019-2024)
8 Regorafenib Market Segmentation by Region
8.1 Global Regorafenib Sales by Region
8.1.1 Global Regorafenib Sales by Region
8.1.2 Global Regorafenib Sales Market Share by Region
8.2 North America
8.2.1 North America Regorafenib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Regorafenib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Regorafenib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Regorafenib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Regorafenib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer Pharmaceuticals
9.1.1 Bayer Pharmaceuticals Regorafenib Basic Information
9.1.2 Bayer Pharmaceuticals Regorafenib Product Overview
9.1.3 Bayer Pharmaceuticals Regorafenib Product Market Performance
9.1.4 Bayer Pharmaceuticals Business Overview
9.1.5 Bayer Pharmaceuticals Regorafenib SWOT Analysis
9.1.6 Bayer Pharmaceuticals Recent Developments
9.2 Beacon Pharmaceuticals
9.2.1 Beacon Pharmaceuticals Regorafenib Basic Information
9.2.2 Beacon Pharmaceuticals Regorafenib Product Overview
9.2.3 Beacon Pharmaceuticals Regorafenib Product Market Performance
9.2.4 Beacon Pharmaceuticals Business Overview
9.2.5 Beacon Pharmaceuticals Regorafenib SWOT Analysis
9.2.6 Beacon Pharmaceuticals Recent Developments
9.3 Drug International
9.3.1 Drug International Regorafenib Basic Information
9.3.2 Drug International Regorafenib Product Overview
9.3.3 Drug International Regorafenib Product Market Performance
9.3.4 Drug International Regorafenib SWOT Analysis
9.3.5 Drug International Business Overview
9.3.6 Drug International Recent Developments
10 Regorafenib Market Forecast by Region
10.1 Global Regorafenib Market Size Forecast
10.2 Global Regorafenib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Regorafenib Market Size Forecast by Country
10.2.3 Asia Pacific Regorafenib Market Size Forecast by Region
10.2.4 South America Regorafenib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Regorafenib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Regorafenib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Regorafenib by Type (2025-2030)
11.1.2 Global Regorafenib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Regorafenib by Type (2025-2030)
11.2 Global Regorafenib Market Forecast by Application (2025-2030)
11.2.1 Global Regorafenib Sales (Kilotons) Forecast by Application
11.2.2 Global Regorafenib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Regorafenib Market Size Comparison by Region (M USD)
Table 5. Global Regorafenib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Regorafenib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Regorafenib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Regorafenib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regorafenib as of 2022)
Table 10. Global Market Regorafenib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Regorafenib Sales Sites and Area Served
Table 12. Manufacturers Regorafenib Product Type
Table 13. Global Regorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Regorafenib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Regorafenib Market Challenges
Table 22. Global Regorafenib Sales by Type (Kilotons)
Table 23. Global Regorafenib Market Size by Type (M USD)
Table 24. Global Regorafenib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Regorafenib Sales Market Share by Type (2019-2024)
Table 26. Global Regorafenib Market Size (M USD) by Type (2019-2024)
Table 27. Global Regorafenib Market Size Share by Type (2019-2024)
Table 28. Global Regorafenib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Regorafenib Sales (Kilotons) by Application
Table 30. Global Regorafenib Market Size by Application
Table 31. Global Regorafenib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Regorafenib Sales Market Share by Application (2019-2024)
Table 33. Global Regorafenib Sales by Application (2019-2024) & (M USD)
Table 34. Global Regorafenib Market Share by Application (2019-2024)
Table 35. Global Regorafenib Sales Growth Rate by Application (2019-2024)
Table 36. Global Regorafenib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Regorafenib Sales Market Share by Region (2019-2024)
Table 38. North America Regorafenib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Regorafenib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Regorafenib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Regorafenib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Regorafenib Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Pharmaceuticals Regorafenib Basic Information
Table 44. Bayer Pharmaceuticals Regorafenib Product Overview
Table 45. Bayer Pharmaceuticals Regorafenib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Pharmaceuticals Business Overview
Table 47. Bayer Pharmaceuticals Regorafenib SWOT Analysis
Table 48. Bayer Pharmaceuticals Recent Developments
Table 49. Beacon Pharmaceuticals Regorafenib Basic Information
Table 50. Beacon Pharmaceuticals Regorafenib Product Overview
Table 51. Beacon Pharmaceuticals Regorafenib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Beacon Pharmaceuticals Business Overview
Table 53. Beacon Pharmaceuticals Regorafenib SWOT Analysis
Table 54. Beacon Pharmaceuticals Recent Developments
Table 55. Drug International Regorafenib Basic Information
Table 56. Drug International Regorafenib Product Overview
Table 57. Drug International Regorafenib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Drug International Regorafenib SWOT Analysis
Table 59. Drug International Business Overview
Table 60. Drug International Recent Developments
Table 61. Global Regorafenib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Global Regorafenib Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. North America Regorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. North America Regorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Europe Regorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 66. Europe Regorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Asia Pacific Regorafenib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 68. Asia Pacific Regorafenib Market Size Forecast by Region (2025-2030) & (M USD)
Table 69. South America Regorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 70. South America Regorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 71. Middle East and Africa Regorafenib Consumption Forecast by Country (2025-2030) & (Units)
Table 72. Middle East and Africa Regorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 73. Global Regorafenib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 74. Global Regorafenib Market Size Forecast by Type (2025-2030) & (M USD)
Table 75. Global Regorafenib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 76. Global Regorafenib Sales (Kilotons) Forecast by Application (2025-2030)
Table 77. Global Regorafenib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Regorafenib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Regorafenib Market Size (M USD), 2019-2030
Figure 5. Global Regorafenib Market Size (M USD) (2019-2030)
Figure 6. Global Regorafenib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Regorafenib Market Size by Country (M USD)
Figure 11. Regorafenib Sales Share by Manufacturers in 2023
Figure 12. Global Regorafenib Revenue Share by Manufacturers in 2023
Figure 13. Regorafenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Regorafenib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Regorafenib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Regorafenib Market Share by Type
Figure 18. Sales Market Share of Regorafenib by Type (2019-2024)
Figure 19. Sales Market Share of Regorafenib by Type in 2023
Figure 20. Market Size Share of Regorafenib by Type (2019-2024)
Figure 21. Market Size Market Share of Regorafenib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Regorafenib Market Share by Application
Figure 24. Global Regorafenib Sales Market Share by Application (2019-2024)
Figure 25. Global Regorafenib Sales Market Share by Application in 2023
Figure 26. Global Regorafenib Market Share by Application (2019-2024)
Figure 27. Global Regorafenib Market Share by Application in 2023
Figure 28. Global Regorafenib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Regorafenib Sales Market Share by Region (2019-2024)
Figure 30. North America Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Regorafenib Sales Market Share by Country in 2023
Figure 32. U.S. Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Regorafenib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Regorafenib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Regorafenib Sales Market Share by Country in 2023
Figure 37. Germany Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Regorafenib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Regorafenib Sales Market Share by Region in 2023
Figure 44. China Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Regorafenib Sales and Growth Rate (Kilotons)
Figure 50. South America Regorafenib Sales Market Share by Country in 2023
Figure 51. Brazil Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Regorafenib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Regorafenib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Regorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Regorafenib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Regorafenib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Regorafenib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Regorafenib Market Share Forecast by Type (2025-2030)
Figure 65. Global Regorafenib Sales Forecast by Application (2025-2030)
Figure 66. Global Regorafenib Market Share Forecast by Application (2025-2030)
